Amino acid formula with vitamins and minerals without methionine and supplemented with arachidonic acid and docosahexaenoic acid
Brand: HCU explore5
PBAC's latest decision on Amino acid formula with vitamins and minerals without methionine and supplemented with arachidonic acid and docosahexaenoic acid: Recommended with restriction (2023). Considered for Dietary management of pyridoxine non-responsive homocystinuria (HCU), expected to be used in infants and young children from 6 months to 5 years of age.
PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2023
Submissions
1
2023 → 2023
Eligible population
Infants and young children from 6 months to 5 years of age with pyridoxine non-responsive homocystinuria.
Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Cost-minimisation
Primary endpoint
Cost-minimisation
Comparator
HCU gel
Economic model
Cost-minimisation
Eligible patients/year
1
ICER note
Cost-minimisation analysis; no ICER calculated by design.